Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease

NCT06809413 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Fluoroquinolone
Mycobacterium

Interventions

DRUG: Sitafloxacin

Sponsor

Beijing Chest Hospital